Multiple endocrine neoplasia type 1-associated thyrotropin-producing pituitary carcinoma: report of a probable de novo example

Human Pathology

Volumn 40, Issue 2, 2009, Pages 270-278

  Scheithauer, Bernd W ^a   Kovacs, Kalman ^b   Nose, Vania ^c   Lombardero, Matilde ^d   Osamura, Yoshiyuki R ^e   Lloyd, Ricardo V ^a   Horvath, Eva ^b   Pagenstecher, Axel ^f   Bohl, Jürgen E ^g   Tews, Dominique S ^h  

^a MAYO CLINIC   (United States)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^e TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f PHILIPPS UNIVERSITY MARBURG   (Germany)

^g UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^h UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

De novo malignancy; MEN 1 syndrome; Pituitary; Plurihormonality; TSH cell carcinoma; Ultrastructure

Indexed keywords

CYCLIN D1; CYCLOOXYGENASE 2; DNA TOPOISOMERASE (ATP HYDROLYSING); EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; LIOTHYRONINE; OCTREOTIDE; PROGESTERONE RECEPTOR; PROLACTIN; PROPYLTHIOURACIL; PROTEIN P27; PROTEIN P53; SECURIN; SEROTONIN; SOMATOSTATIN; THYROTROPIN; THYROXINE; UVOMORULIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ADULT; ALPHA CHAIN; ARTICLE; CANCER MORPHOLOGY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CHRONIC INFLAMMATION; COMPUTER ASSISTED TOMOGRAPHY; CRANIOSPINAL METASTASIS; DISEASE ASSOCIATION; DISEASE COURSE; ELECTRON MICROSCOPY; FIBROSIS; HEADACHE; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; HYPOPHYSECTOMY; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LIOTHYRONINE BLOOD LEVEL; LYMPH NODE BIOPSY; MALE; METASTASIS; MICROVASCULATURE; MITOSIS RATE; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARATHYROIDECTOMY; PREOPERATIVE EVALUATION; SPINAL CORD DECOMPRESSION; THYROTROPIN BLOOD LEVEL; THYROTROPIN SECRETING ADENOMA; THYROXINE BLOOD LEVEL; VISUAL DISORDER;

ADULT; CARCINOMA; CENTRAL NERVOUS SYSTEM NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PITUITARY NEOPLASMS; PROLACTIN; THYROTROPIN;

EID: 58149121315     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.06.013     Document Type: Article

References (47)

1. Brucker-Davis F., Oldfield E.H., Skarulis M.C., Doppman J.L., and Weintraub B.D. Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84 (1999) 476-486
2. Beck-Peccoz P., Brucker-Davis F., Persani L., Smallridge R.C., and Weintraub B.D. Thyrotropin-secreting pituitary tumors. Endocr Rev 17 (1996) 610-638
3. McCutcheon I.E., Weintraub B.D., and Oldfield E.H. Surgical treatment of thyrotropin-secreting pituitary adenomas. J Neurosurg 73 (1990) 674-683
4. Pernicone P.J., Scheithauer B.W., Sebo T.J., et al. Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer 79 (1997) 804-812
5. Mixson A.J., Friedman T.C., Katz D.A., et al. Thyrotropin-secreting pituitary carcinoma. J Clin Endocrinol Metab 76 (1993) 529-533
6. O'Brien D.P., Phillips J.P., Rawluk D.R., and Farrell M.A. Intracranial metastases from pituitary adenoma. Br J Neurosurg 9 (1995) 211-218
7. Brown R.L., Muzzafar T., Wollman R., and Weiss R.E. A pituitary carcinoma secreting TSH and prolactin: a non-secreting adenoma gone awry. Eur J Endocrinol 154 (2006) 639-643
8. Cai W.Y., Alexander J.M., Hedley-Whyte E.T., et al. ras mutations in human prolactinomas and pituitary carcinomas. J Clin Endocrinol Metab 78 (1994) 89-93
9. Farrell W.E., and Clayton R.N. Molecular pathogenesis of pituitary tumors. Front Neuroendocrinol 21 (2000) 174-198
10. Jin L., Qian X., Kulig E., et al. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries. Am J Pathol 151 (1997) 509-519
11. Pei L., Melmed S., Scheithauer B., Kovacs K., and Prager D. H-ras mutations in human pituitary carcinoma metastases. J Clin Endocrinol Metab 78 (1994) 842-846
12. Pernicone P.J., and Scheithauer B.W. Invasive pituitary adenomas and pituitary carcinomas (2000), Humana Press, Boca Raton
13. Roncaroli F., Nose V., Scheithauer B.W., et al. Gonadotropic pituitary carcinoma: HER-2/neu expression and gene amplification. Report of two cases. J Neurosurg 99 (2003) 402-408
14. Scheithauer B.W., Gaffey T.A., Lloyd R.V., et al. Pathobiology of pituitary adenomas and carcinomas. Neurosurgery 59 (2006) 341-353 discussion 341-353
15. Thapar K., Kovacs K., Scheithauer B.W., et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38 (1996) 99-106 discussion 106-107
16. Thapar K., Scheithauer B.W., Kovacs K., Pernicone P.J., and Laws Jr. E.R. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 38 (1996) 765-770 discussion 770-761
17. Scheithauer B.W., Kurtkaya-Yapicier O., Kovacs K.T., Young Jr. W.F., and Lloyd R.V. Pituitary carcinoma: a clinicopathological review. Neurosurgery 56 (2005) 1066-1074
18. Kovacs K., Lloyd R., Horvath E., et al. Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization. Am J Pathol 134 (1989) 345-353
19. Kovacs K., Stefaneanu L., Horvath E., et al. Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization. Virchows Arch A Pathol Anat Histopathol 418 (1991) 439-446
20. Vidal S., Kovacs K., Horvath E., Scheithauer B.W., Kuroki T., and Lloyd R.V. Microvessel density in pituitary adenomas and carcinomas. Virchows Arch 438 (2001) 595-602
21. Gaffey T.A., Scheithauer B.W., Lloyd R.V., et al. Corticotroph carcinoma of the pituitary: a clinicopathological study. Report of four cases. J Neurosurg 96 (2002) 352-360
22. Hunter J.A., Skelly R.H., Aylwin S.J., et al. The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas. Eur J Endocrinol 148 (2003) 203-211
23. Minematsu T., Suzuki M., Sanno N., Takekoshi S., Teramoto A., and Osamura R.Y. PTTG overexpression is correlated with angiogenesis in human pituitary adenomas. Endocr Pathol 17 (2006) 143-153
24. Onofri C., Theodoropoulou M., Losa M., et al. Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours. J Endocrinol 191 (2006) 249-261
25. Vidal S., Horvath E., Kovacs K., Kuroki T., Lloyd R.V., and Scheithauer B.W. Expression of hypoxia-inducible factor-1alpha (HIF-1alpha) in pituitary tumours. Histol Histopathol 18 (2003) 679-686
26. Kim K., Yoshida D., and Teramoto A. Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in pituitary adenomas. Endocr Pathol 16 (2005) 115-121
27. Wolfsberger S., Wunderer J., Zachenhofer I., et al. Expression of cell proliferation markers in pituitary adenomas-correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha. Acta Neurochir (Wien) 146 (2004) 831-839
28. Onguru O., Scheithauer B.W., Kovacs K., et al. Analysis of Cox-2 and thromboxane synthase expression in pituitary adenomas and carcinomas. Endocr Pathol 15 (2004) 17-27
29. Filippella M., Galland F., Kujas M., et al. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study. Clin Endocrinol (Oxf) 65 (2006) 536-543
30. McCabe C.J., Khaira J.S., Boelaert K., et al. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour. Clin Endocrinol (Oxf) 58 (2003) 141-150
31. Qian Z.R., Li C.C., Yamasaki H., et al. Role of E-cadherin, alpha-, beta-, and gamma-catenins, and p120 (cell adhesion molecules) in prolactinoma behavior. Mod Pathol 15 (2002) 1357-1365
32. Hibberts N.A., Simpson D.J., Bicknell J.E., et al. Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors. Clin Cancer Res 5 (1999) 2133-2139
33. Turner H.E., Nagy Z., Sullivan N., Esiri M.M., and Wass J.A. Expression analysis of cyclins in pituitary adenomas and the normal pituitary gland. Clin Endocrinol (Oxf) 53 (2000) 337-344
34. Vidal S., Kovacs K., Bell D., Horvath E., Scheithauer B.W., and Lloyd R.V. Cyclooxygenase-2 expression in human pituitary tumors. Cancer 97 (2003) 2814-2821
35. Benito M., Asa S.L., Livolsi V.A., West V.A., and Snyder P.J. Gonadotroph tumor associated with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 90 (2005) 570-574
36. Scheithauer B.W., Laws Jr. E.R., Kovacs K., Horvath E., Randall R.V., and Carney J.A. Pituitary adenomas of the multiple endocrine neoplasia type I syndrome. Semin Diagn Pathol 4 (1987) 205-211
37. Scheithauer B.W., Kovacs K.T., Laws Jr. E.R., and Randall R.V. Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65 (1986) 733-744
38. Sautner D., and Saeger W. Invasiveness of pituitary adenomas. Pathol Res Pract 187 (1991) 632-636
39. Gesundheit N., Petrick P.A., Nissim M., et al. Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients. Ann Intern Med 111 (1989) 827-835
40. Hill S.A., Falko J.M., Wilson C.B., and Hunt W.E. Thyrotrophin-producing pituitary adenomas. J Neurosurg 57 (1982) 515-519
41. Sanno N., Teramoto A., and Osamura R.Y. Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma. J Neurosurg 93 (2000) 194-200
42. Kovacs K., Bell D., Gardiner G.W., Honey R.J., Goguen J., and Rotondo F. Malignant paraganglioma of the urinary bladder: immunohistochemical study of prognostic indicators. Endocr Pathol 16 (2005) 363-369
43. Sautner D., Saeger W., Tallen G., Ludecke D.K., and Rehpenning W. Effects of octreotide on morphology of pituitary adenomas in acromegaly. Pathol Res Pract 189 (1993) 1044-1051
44. Selman W.R., Laws Jr. E.R., Scheithauer B.W., and Carpenter S.M. The occurrence of dural invasion in pituitary adenomas. J Neurosurg 64 (1986) 402-407
45. Anniko M., Tribukait B., and Wersall J. DNA ploidy and cell phase in human pituitary carcinoma. Skull Base Surg 28 (1987) 71-76
46. Hsu D.W., Hakim F., Biller B.M., et al. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg 78 (1993) 753-761
47. Lopes M.B., Scheithauer B.W., and Schiff D. Pituitary carcinoma: diagnosis and treatment. Endocrine 28 (2005) 115-121